|
CN101712721A
(zh)
*
|
2000-06-05 |
2010-05-26 |
阿尔托生物科学有限公司 |
T细胞受体融合物及共轭物以及其使用方法
|
|
CA2487779C
(en)
|
2001-06-05 |
2012-10-02 |
Altor Bioscience Corporation |
P53 binding t cell receptor molecules and uses thereof
|
|
AU2003286263A1
(en)
*
|
2002-12-03 |
2004-06-23 |
Avidex Ltd. |
Complexes of receptors
|
|
JP3803790B2
(ja)
*
|
2003-02-17 |
2006-08-02 |
株式会社東北テクノアーチ |
新規なダイアボディ型二重特異性抗体
|
|
CN1901839A
(zh)
*
|
2003-11-10 |
2007-01-24 |
阿尔特生物科学公司 |
可溶性tcr分子及其用途
|
|
US7964380B2
(en)
*
|
2005-01-21 |
2011-06-21 |
Argylia Technologies |
Nanoparticles for manipulation of biopolymers and methods of thereof
|
|
GB0507046D0
(en)
*
|
2005-04-06 |
2005-05-11 |
Celltech R&D Ltd |
Primers
|
|
US20080299137A1
(en)
*
|
2005-10-28 |
2008-12-04 |
Novo Nordisk A/S |
Fusion Proteins That Bind Effector Lymphocytes And Target Cells
|
|
EP1982176A1
(en)
*
|
2006-01-30 |
2008-10-22 |
Dako Denmark A/S |
High-speed quantification of antigen specific t-cells in whole blood by flow cytometry
|
|
LT2029173T
(lt)
|
2006-06-26 |
2016-11-10 |
Macrogenics, Inc. |
Fc riib specifiniai antikūnai ir jų panaudojimo būdai
|
|
FR2902799B1
(fr)
|
2006-06-27 |
2012-10-26 |
Millipore Corp |
Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide
|
|
US20100210478A1
(en)
*
|
2006-06-29 |
2010-08-19 |
Xiaolian Gao |
Make and use of surface molecules of varied densities
|
|
US8362217B2
(en)
|
2006-12-21 |
2013-01-29 |
Emd Millipore Corporation |
Purification of proteins
|
|
US8569464B2
(en)
|
2006-12-21 |
2013-10-29 |
Emd Millipore Corporation |
Purification of proteins
|
|
WO2008079280A1
(en)
|
2006-12-21 |
2008-07-03 |
Millipore Corporation |
Purification of proteins
|
|
EP2155782A2
(en)
|
2007-03-26 |
2010-02-24 |
Dako Denmark A/S |
Mhc peptide complexes and uses thereof in infectious diseases
|
|
EP2167536A1
(en)
|
2007-07-03 |
2010-03-31 |
Dako Denmark A/S |
Mhc multimers, methods for their generation, labeling and use
|
|
WO2009039854A2
(en)
|
2007-09-27 |
2009-04-02 |
Dako Denmark A/S |
Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
|
|
US10968269B1
(en)
|
2008-02-28 |
2021-04-06 |
Agilent Technologies, Inc. |
MHC multimers in borrelia diagnostics and disease
|
|
US20110070191A1
(en)
*
|
2008-03-19 |
2011-03-24 |
Wong Hing C |
T cell receptor fusions and conjugates and methods of use there of
|
|
WO2009151514A1
(en)
*
|
2008-06-11 |
2009-12-17 |
Millipore Corporation |
Stirred tank bioreactor
|
|
EP2769711A1
(en)
*
|
2008-07-10 |
2014-08-27 |
ESBATech, an Alcon Biomedical Research Unit LLC |
Methods and Compositions for Enhanced Delivery of Macromolecules
|
|
US10722562B2
(en)
*
|
2008-07-23 |
2020-07-28 |
Immudex Aps |
Combinatorial analysis and repair
|
|
GB0817244D0
(en)
*
|
2008-09-20 |
2008-10-29 |
Univ Cardiff |
Use of a protein kinase inhibitor to detect immune cells, such as T cells
|
|
US10369204B2
(en)
|
2008-10-02 |
2019-08-06 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
|
US11992518B2
(en)
|
2008-10-02 |
2024-05-28 |
Agilent Technologies, Inc. |
Molecular vaccines for infectious disease
|
|
CN105037535A
(zh)
|
2008-12-16 |
2015-11-11 |
Emd密理博公司 |
搅拌槽反应器及方法
|
|
EP2258719A1
(en)
|
2009-05-19 |
2010-12-08 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Multiple target T cell receptor
|
|
GB0908613D0
(en)
*
|
2009-05-20 |
2009-06-24 |
Immunocore Ltd |
T Cell Reseptors
|
|
DK2571903T3
(da)
|
2010-05-17 |
2019-11-04 |
Emd Millipore Corp |
Polymerer, der reagerer på stimuli, til oprensning af biomolekyler
|
|
EP2580349A2
(en)
*
|
2010-06-08 |
2013-04-17 |
EMD Millipore Corporation |
Methods of detecting residual amounts of polymers used in the purification of biomolecules
|
|
JP2014530009A
(ja)
|
2011-09-29 |
2014-11-17 |
エーピーオー‐ティー ビー．ヴイ． |
異常細胞を標的とする多重特異性結合分子
|
|
CN104114695B
(zh)
|
2011-10-05 |
2018-04-17 |
洛克菲勒大学 |
二聚噬菌体溶素
|
|
KR101963230B1
(ko)
|
2011-12-26 |
2019-03-29 |
삼성전자주식회사 |
복수개의 단일 항체를 포함하는 단백질 복합체
|
|
SG10201705698PA
(en)
|
2012-01-13 |
2017-08-30 |
Apo-T B V |
Aberrant Cell-Restricted Immunoglobulins Provided With A Toxic Moiety
|
|
UA114108C2
(uk)
|
2012-07-10 |
2017-04-25 |
Борд Оф Ріджентс, Дзе Юніверсіті Оф Техас Сістем |
Моноклональне антитіло для застосування в діагностиці і терапії злоякісних пухлин і аутоімунного захворювання
|
|
US20150183877A1
(en)
*
|
2012-07-18 |
2015-07-02 |
Eli Lilly And Company |
Multi-Specific IgG-(Fab)2 Constructs Containing T-Cell Receptor Constant Domains
|
|
KR101911438B1
(ko)
|
2012-10-31 |
2018-10-24 |
삼성전자주식회사 |
이중 특이 항원 결합 단백질 복합체 및 이중 특이 항체의 제조 방법
|
|
ES2776698T3
(es)
|
2012-12-20 |
2020-07-31 |
Purdue Research Foundation |
Células T que expresan un receptor antigénico quimérico como terapia contra el cáncer
|
|
BR112016011567A2
(pt)
|
2013-11-22 |
2017-10-24 |
Hutchinson Fred Cancer Res |
receptores de célula t humana de alta afinidade geneticamente modificados.
|
|
US10816554B2
(en)
*
|
2014-04-04 |
2020-10-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Ligand discovery for T cell receptors
|
|
PE20170286A1
(es)
|
2014-07-01 |
2017-03-30 |
Pfizer |
Diacuerpos heterodimericos biespecificos y sus usos
|
|
JP7282521B2
(ja)
|
2016-04-08 |
2023-05-29 |
パーデュー・リサーチ・ファウンデイション |
Ｃａｒ ｔ細胞療法のための方法および組成物
|
|
ES3008636T3
(en)
|
2016-06-02 |
2025-03-24 |
Immunocore Ltd |
Dosing regimen for gp100-specific tcr - anti-cd3 scfv fusion protein
|
|
US11649288B2
(en)
|
2017-02-07 |
2023-05-16 |
Seattle Children's Hospital |
Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents
|
|
CA3221995C
(en)
|
2017-02-08 |
2024-05-28 |
Dragonfly Therapeutics, Inc. |
Multi-specific binding proteins for activation of natural killer cells and therapeutic uses thereof to treat cancer
|
|
SG11201907646YA
(en)
|
2017-02-20 |
2019-09-27 |
Dragonfly Therapeutics Inc |
Proteins binding her2, nkg2d and cd16
|
|
WO2018160622A1
(en)
|
2017-02-28 |
2018-09-07 |
Endocyte, Inc. |
Compositions and methods for car t cell therapy
|
|
WO2018166589A1
(en)
*
|
2017-03-15 |
2018-09-20 |
Biontech Cell & Gene Therapies Gmbh |
Antigen receptors and uses thereof
|
|
EP3675897A1
(en)
|
2017-09-01 |
2020-07-08 |
Dana Farber Cancer Institute, Inc. |
Immunogenic peptides specific to bcma and taci antigens for treatment of cancer
|
|
CN112292138A
(zh)
|
2018-01-22 |
2021-01-29 |
西雅图儿童医院（Dba西雅图儿童研究所） |
Car t细胞的使用方法
|
|
SG11202007426XA
(en)
|
2018-02-06 |
2020-09-29 |
Seattle Childrens Hospital Dba Seattle Childrens Res Inst |
Fluorescein-specific cars exhibiting optimal t cell function against fl-ple labelled tumors
|
|
PT3749346T
(pt)
|
2018-02-08 |
2024-09-05 |
Dragonfly Therapeutics Inc |
Combinações de domínios variáveis de anticorpos dirigidas ao receptor nkg2d
|
|
KR20200118824A
(ko)
|
2018-02-08 |
2020-10-16 |
드래곤플라이 쎄라퓨틱스, 인크. |
자연 살해 세포를 활성화시키는 다중-특이성 결합 단백질을 수반하는 암의 병용 요법
|
|
CA3091424A1
(en)
|
2018-02-20 |
2019-08-29 |
Dragonfly Therapeutics, Inc. |
Multi-specific binding proteins that bind cd33, nkg2d, and cd16, and methods of use
|
|
WO2019165237A1
(en)
|
2018-02-23 |
2019-08-29 |
Endocyte, Inc. |
Sequencing method for car t cell therapy
|
|
CA3108646A1
(en)
|
2018-08-08 |
2020-02-13 |
Dragonfly Therapeutics, Inc. |
Proteins binding nkg2d, cd16 and a tumor-associated antigen
|
|
EA202091888A1
(ru)
|
2018-08-08 |
2020-10-23 |
Драгонфлай Терапьютикс, Инк. |
Вариабельные домены антител, нацеленные на рецептор nkg2d
|
|
AU2019318083A1
(en)
|
2018-08-08 |
2021-02-25 |
Dragonfly Therapeutics, Inc. |
Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of use
|
|
US12258373B2
(en)
|
2018-12-17 |
2025-03-25 |
Immudex Aps |
Panel comprising Borrelia MHC multimers
|
|
US12448429B2
(en)
|
2019-03-06 |
2025-10-21 |
Dana-Farber Cancer Institute, Inc. |
T cell receptors specific to b-cell maturation antigen for treatment of cancer
|
|
MX2022013944A
(es)
|
2020-05-06 |
2022-11-30 |
Dragonfly Therapeutics Inc |
Proteinas que se unen al receptor activador de celulas asesinas naturales grupo 2 miembro d (nkg2d), cumulo de diferenciacion (cd16) y miembro a de la familia de dominios de lectina tipo c 12 (clec12a).
|
|
JP2024508894A
(ja)
|
2021-03-03 |
2024-02-28 |
ドラゴンフライ セラピューティクス， インコーポレイテッド |
Ｎｋｇ２ｄ、ｃｄ１６、及び腫瘍関連抗原に結合する多特異性結合タンパク質を使用して癌を治療する方法
|
|
MX2023012899A
(es)
|
2021-05-05 |
2023-11-08 |
Immatics Biotechnologies Gmbh |
Polipeptidos de union a antigeno bma031 mejorados.
|
|
AU2024205968A1
(en)
*
|
2023-01-05 |
2025-08-07 |
Angeles Therapeutics, Inc. |
Methods and compositions for gene transduction and to control the activity of synthetic and immune receptors
|
|
GB202320012D0
(en)
*
|
2023-12-22 |
2024-02-07 |
Immunocore Ltd |
Bispecific molecules
|